Close Menu

Taking the time for a coffee break — and the ensuing conversations with colleagues — helped Thomas Steitz on his way to the Nobel prize in chemistry. According to the Associated Press, Steitz was surprised by all the breaks in the day at Cambridge University. "What a fabulous place! Coffee in the morning, lunch in the afternoon, tea in the afternoon, I wondered how does anyone get any science done," he says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.